Anti-cytokine vaccines and the immunotherapy of autoimmune diseases
- PMID: 17072913
- PMCID: PMC2615480
- DOI: 10.1002/eji.200636760
Anti-cytokine vaccines and the immunotherapy of autoimmune diseases
Abstract
Three papers in this issue of the European Journal of Immunology describe the use of cytokine vaccines to prevent autoimmune disease in experimental animals. The vaccines are based on interleukin 17 (IL-17), a cytokine that has recently been shown to play a central role in inflammation.
Figures
Comment on
-
Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis.Eur J Immunol. 2006 Nov;36(11):2849-56. doi: 10.1002/eji.200636484. Eur J Immunol. 2006. PMID: 17039570
-
Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.Eur J Immunol. 2006 Nov;36(11):2857-67. doi: 10.1002/eji.200636658. Eur J Immunol. 2006. PMID: 17048275
-
Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis.Eur J Immunol. 2006 Nov;36(11):2868-74. doi: 10.1002/eji.200636662. Eur J Immunol. 2006. PMID: 17048276
References
-
- Mosmann TR, Coffman RL. Two types of mouse helper T-cell clone. Implications for immune regulation. Immunol. Today. 1987;8:223–227. - PubMed
-
- Khoruts A, Miller SD, Jenkins MK. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol. 1995;155:5011–5017. - PubMed
-
- Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 1995;268:1185–1188. - PubMed
-
- McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006;27:17–23. - PubMed
-
- Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T-cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 1995;16:34–38. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
